These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 20346928

  • 1. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
    Shimizu M, Shirakami Y, Sakai H, Yasuda Y, Kubota M, Adachi S, Tsurumi H, Hara Y, Moriwaki H.
    Chem Biol Interact; 2010 May 14; 185(3):247-52. PubMed ID: 20346928
    [Abstract] [Full Text] [Related]

  • 2. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
    Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB.
    Biochem Biophys Res Commun; 2005 Sep 02; 334(3):947-53. PubMed ID: 16053920
    [Abstract] [Full Text] [Related]

  • 3. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
    Tang XD, Zhou X, Zhang QZ, Le AD, Zhou KY.
    Zhonghua Yi Xue Za Zhi; 2008 Nov 04; 88(40):2872-7. PubMed ID: 19080502
    [Abstract] [Full Text] [Related]

  • 4. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Shimizu M, Deguchi A, Joe AK, Mckoy JF, Moriwaki H, Weinstein IB.
    J Exp Ther Oncol; 2005 Nov 04; 5(1):69-78. PubMed ID: 16416603
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y, Shimizu M, Adachi S, Sakai H, Nakagawa T, Yasuda Y, Tsurumi H, Hara Y, Moriwaki H.
    Cancer Sci; 2009 Oct 04; 100(10):1957-62. PubMed ID: 19558547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
    Park JS, Kim MH, Chang HJ, Kim KM, Kim SM, Shin BA, Ahn BW, Jung YD.
    Int J Oncol; 2006 Nov 04; 29(5):1247-52. PubMed ID: 17016658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 11. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
    Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, Borea PA.
    Mol Pharmacol; 2007 Aug 27; 72(2):395-406. PubMed ID: 17488804
    [Abstract] [Full Text] [Related]

  • 12. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L, Zhang E, Shi J, Li X, Zhou K, Zhang Q, Le AD, Tang X.
    Cancer Chemother Pharmacol; 2013 Mar 27; 71(3):713-25. PubMed ID: 23292117
    [Abstract] [Full Text] [Related]

  • 13. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ.
    Int J Oncol; 2008 Mar 27; 32(3):585-92. PubMed ID: 18292935
    [Abstract] [Full Text] [Related]

  • 14. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M, Murakami A, Kawabata K, Ohigashi H.
    Carcinogenesis; 2005 Sep 27; 26(9):1553-62. PubMed ID: 15860507
    [Abstract] [Full Text] [Related]

  • 15. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice.
    Shimizu M, Shirakami Y, Sakai H, Adachi S, Hata K, Hirose Y, Tsurumi H, Tanaka T, Moriwaki H.
    Cancer Prev Res (Phila); 2008 Sep 27; 1(4):298-304. PubMed ID: 19138973
    [Abstract] [Full Text] [Related]

  • 16. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Rieger-Christ KM, Hanley R, Lodowsky C, Bernier T, Vemulapalli P, Roth M, Kim J, Yee AS, Le SM, Marie PJ, Libertino JA, Summerhayes IC.
    J Cell Biochem; 2007 Oct 01; 102(2):377-88. PubMed ID: 17348027
    [Abstract] [Full Text] [Related]

  • 17. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ, Fan LF, Liu ZS, Qian Q, Xia D, Diao LM, He YM, Ai ZL.
    Chin Med J (Engl); 2004 Oct 01; 117(10):1541-6. PubMed ID: 15498380
    [Abstract] [Full Text] [Related]

  • 18. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.
    Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi X, Fang J, Jiang BH.
    Free Radic Biol Med; 2006 Nov 15; 41(10):1521-33. PubMed ID: 17045920
    [Abstract] [Full Text] [Related]

  • 19. Epigallocatechin-3-gallate inhibits IGF-I-stimulated lung cancer angiogenesis through downregulation of HIF-1α and VEGF expression.
    Li X, Feng Y, Liu J, Feng X, Zhou K, Tang X.
    J Nutrigenet Nutrigenomics; 2013 Nov 15; 6(3):169-78. PubMed ID: 24008975
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.
    Int J Oncol; 2007 Oct 15; 31(4):705-11. PubMed ID: 17786300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.